Sentinel node biopsy in breast cancer revisited

Abstract The axilla has long been a focus of clinicians' attention in the management of breast cancer. The approach to the axilla has undergone dramatic changes over the last century, from radical and extended radical excisions, through the introduction of sentinel node biopsy for node negative...

Full description

Saved in:
Bibliographic Details
Published inThe surgeon (Edinburgh) Vol. 12; no. 3; pp. 158 - 165
Main Authors Omair, Mohammad, Al-Azawi, Dhafir, Mann, Gregory Bruce
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The axilla has long been a focus of clinicians' attention in the management of breast cancer. The approach to the axilla has undergone dramatic changes over the last century, from radical and extended radical excisions, through the introduction of sentinel node biopsy for node negative patients to the current situation where selective management of those with nodal involvement is being introduced. The introduction of lymphatic mapping and sentinel node biopsy in the 1990's has been key to the major changes that have occurred. In less than 20 years it has moved from a hypothesis to a situation where it is the default approach to almost all clinically node negative patients and is being considered in other situations where axillary clearance was previously considered standard. This article reviews the development and introduction of sentinel node biopsy, its current uncertainties and limitations, and possible future developments.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1479-666X
2405-5840
DOI:10.1016/j.surge.2013.12.007